Patent · US Active

Prostate neoantigens and their uses

US12295997B2 · kind B2 · utility

0Cited by
119References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2021
Grant dateMay 13, 2025
Priority date—
Expiry dateMar 20, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/36143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are self-replicating RNA molecules encoding prostate neoantigens, vaccines, and methods of treating and preventing prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.